Project Grant F31DK148130
Award Date 2/1/27
Completion Date 6/30/27
Dollars Obligated $100K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Baylor College of Medicine $200,000 on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, assistance type Project Grant). The funded research investigates how proteostatic stress—arising from fever-range hyperthermia, altered oxygen tension, and modulation of protein quality control pathways including chaperones, proteasome activity, autophagy, and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Dana-Farber Cancer Institute, Inc. $740,581 on April 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to fund basic research on niche regulation of gastric epithelial cell differentiation. The award funds investigation of how distinct stomach epithelial cell types—pit, isthmus, neck, and chief cells—arise from a common multipotential progenitor and are regulated by...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Baylor College of Medicine $149,190 on December 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct basic research modeling intestinal stem cell regulation during aging. The recipient will use Drosophila melanogaster to investigate mechanisms controlling the transition between active and quiescent states in intestinal stem cells, with particular focus on a...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the Scripps Research Institute $152,600 on February 15, 2027, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds research examining how hepatic endoplasmic reticulum (ER) stress affects the integrity of the secreted proteome, with focus on protein aggregation diseases including systemic amyloidoses. The research will use established and novel proteomics...
- The National Institute of Diabetes and Digestive and Kidney Diseases, part of the Department of Health and Human Services National Institutes of Health, awarded Baylor College of Medicine $167,165 on July 2, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate molecular mechanisms of T cell dysfunction in pediatric chronic cholestatic liver diseases. The research program, spanning five years through March 31, 2031, and performed in...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Brigham & Women's Hospital Inc. $730,898 on July 10, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate NR5A2 regulatory mechanisms in pancreas health and disease. The research examines how the transcription factor NR5A2 governs acinar cell identity and its role in preventing acinar-to-ductal metaplasia, a reversible process occurring during acute...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Leland Stanford Junior University $611,189 on September 3, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the molecular mechanisms of epithelial symmetry breaking and repair. The research examines the roles of E-cadherin and PAR-3 proteins in establishing apical-basolateral polarity within epithelial tissues. The study focuses on how unpolarized...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Alabama at Birmingham $718,880 on August 10, 2026, to investigate pancreatic regeneration in conditions caused by genetic mutation under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research develops and utilizes a novel animal model that mimics pancreatic injury and healing in individuals with cystic fibrosis caused by a specific CF gene mutation. The...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Baylor College of Medicine $240,000 on August 27, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop preclinical mouse models expressing HIV proteins that replicate metabolic comorbidities observed in persons living with HIV, including obesity, cardiovascular disease, chronic kidney disease, osteoporosis, cancers, frailty, and cognitive decline. The research...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) $163,665 for a five-year career development and research program on August 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research investigates gastric zymogenic cell plasticity and the role of YAP1 and TAZ proteins in governing the balance between tissue regeneration and...